Inspire Medical Systems (INSP)
(Delayed Data from NYSE)
$237.45 USD
+6.44 (2.79%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $237.47 +0.02 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth D Momentum C VGM
Price, Consensus and EPS Surprise
INSP 237.45 +6.44(2.79%)
Will INSP be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for INSP based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for INSP
Edwards Lifesciences (EW) Q1 Earnings Top, 2024 Sales View Up
Should Lifeward (LFWD) be in Your Portfolio Ahead of Q1 Earnings?
INSP: What are Zacks experts saying now?
Zacks Private Portfolio Services
ResMed (RMD) Q3 Earnings Beat Estimates, Margins Expand
ICON (ICLR) Q1 Earnings Surpass Estimates, Margins Expand
Align Technology (ALGN) Q1 Earnings Top, 2024 Sales View Up
Other News for INSP
Inspire Medical Systems Larger Than S&P 500 Component Comerica
Analysts Have Conflicting Sentiments on These Healthcare Companies: Inspire Medical Systems (INSP) and AdaptHealth (AHCO)
The Latest Analyst Ratings For Inspire Medical Systems
Analysts Are Bullish on These Healthcare Stocks: Gilead Sciences (GILD), Biogen (BIIB)
RBC Capital starts Inspire Medical at outperform, cites first-mover status